Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 90 | 120 | 150 | 0 | 195 |
| Gross Profit | 90 | 120 | 150 | N/A | 195 |
| Operating Expenses | 19,011 | 14,766 | 16,652 | 8,257 | 10,106 |
| Operating Income | -18,921 | -14,647 | -16,502 | -8,257 | -9,912 |
| Other Income | 1,548 | 57 | 659 | 658 | 776 |
| Pre-tax Income | -17,373 | -14,590 | -15,843 | -7,599 | -9,135 |
| Income Tax | N/A | -507 | -357 | N/A | N/A |
| Net Income Continuous | -17,373 | -14,083 | -15,487 | -7,599 | -9,135 |
| Net Income | $-17,373 | $-14,083 | $-15,487 | $-7,599 | $-9,135 |
| EPS Basic Total Ops | -6.50 | -7.50 | -18.00 | -10.50 | -9.00 |
| EPS Basic Continuous Ops | -5.98 | -7.18 | -8.56 | -6.59 | -8.87 |
| EPS Diluted Total Ops | -6.50 | -7.50 | -18.00 | -10.50 | -9.00 |
| EPS Diluted Continuous Ops | -5.98 | -7.18 | -8.56 | -6.59 | -8.87 |
| EPS Diluted Before Non-Recurring Items | -6.50 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-18,140 | $-14,428 | $-16,402 | $-8,205 | $-9,868 |